Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
iShares Core S&P US Growth ETF
IUSG
$31.1B
| $5.05M | ﹤0.01% |
32,571
-1,489
| -4% | -$245K |
|
2402
Theravance Biopharma
TBPH
$874M
| $5.04M | ﹤0.01% |
310,594
-2,700
| -0.9% | -$47.8K |
|
2403
GCM Grosvenor
GCMG
$737M
| $5.03M | ﹤0.01% |
513,256
+80,333
| +19% | +$890K |
|
2404
Certara
CERT
$1.17B
| $5.02M | ﹤0.01% |
880,203
+36,407
| +4% | +$278K |
|
2405
SITE Centers
SITC
$230M
| $5.01M | ﹤0.01% |
927,335
+168,614
| +22% | +$1.03M |
|
2406
Amplitude
AMPL
$1.07B
| $5M | ﹤0.01% |
733,701
-44,693
| -6% | -$369K |
|
|
BETA
2407
Beta Technologies Inc
BETA
$4.2B
| $5M | ﹤0.01% |
340,186
+75,454
| +29% | +$1.55M |
|
2408
Central Garden & Pet Co
CENT
$2.74B
| $4.99M | ﹤0.01% |
135,717
-4,630
| -3% | -$166K |
|
|
FLY
2409
Firefly Aerospace
FLY
$3.23B
| $4.97M | ﹤0.01% |
174,673
+22,543
| +15% | +$549K |
|
2410
Southern Missouri Bancorp
SMBC
$855M
| $4.93M | ﹤0.01% |
77,131
-812
| -1% | -$50.8K |
|
|
NIQ
2411
NIQ Global Intelligence PLC
NIQ
$3.17B
| $4.93M | ﹤0.01% |
433,444
+127,927
| +42% | +$1.73M |
|
2412
Janux Therapeutics
JANX
$935M
| $4.93M | ﹤0.01% |
354,328
-36,178
| -9% | -$496K |
|
|
HTB
2413
HomeTrust Bancshares
HTB
$818M
| $4.92M | ﹤0.01% |
115,383
-4,617
| -4% | -$199K |
|
2414
MasterCraft Boat Holdings
MCFT
$588M
| $4.88M | ﹤0.01% |
237,704
-35,045
| -13% | -$759K |
|
2415
Alerus Financial
ALRS
$822M
| $4.87M | ﹤0.01% |
205,324
-1,876
| -0.9% | -$45.5K |
|
2416
Invesco Mortgage Capital
IVR
$776M
| $4.86M | ﹤0.01% |
601,963
+5,936
| +1% | +$50.6K |
|
2417
Cytek Biosciences
CTKB
$576M
| $4.83M | ﹤0.01% |
1,104,601
+10,062
| +0.9% | +$47.5K |
|
|
SION
2418
Sionna Therapeutics
SION
$2.06B
| $4.82M | ﹤0.01% |
120,253
-3,433
| -3% | -$131K |
|
2419
MGP Ingredients
MGPI
$378M
| $4.82M | ﹤0.01% |
262,146
-29,908
| -10% | -$668K |
|
2420
Kanzhun
BZ
$6.89B
| $4.82M | ﹤0.01% |
359,929
-1,236
| -0.3% | -$20.9K |
|
2421
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $4.79M | ﹤0.01% |
91,203
-12,635
| -12% | -$649K |
|
2422
Rigel Pharmaceuticals
RIGL
$680M
| $4.78M | ﹤0.01% |
176,850
+28,214
| +19% | +$948K |
|
2423
Root
ROOT
$917M
| $4.76M | ﹤0.01% |
107,693
-3,616
| -3% | -$211K |
|
2424
Mission Produce
AVO
$1.1B
| $4.76M | ﹤0.01% |
345,690
-5,506
| -2% | -$73.3K |
|
2425
SmartFinancial
SMBK
$855M
| $4.75M | ﹤0.01% |
121,655
+369
| +0.3% | +$14.6K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.